Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism
Authors:
- 20 March 2006
- journal article
- Published by Wiley in Clinical and Laboratory Haematology
- Vol. 28 (2) , 111-116
Abstract
Venous thromboembolism (VTE) is a common vascular disease that results in two major clinical manifestations: deep venous thrombosis (DVT) and pulmonary embolism (PE). Several genetic risk factors, especially factor V Leiden and prothrombin G20210A mutations have been reported to be related to VTE in Caucasians, but the relationship remains controversial in other populations. Thus, the objective of the present study was to compare the frequency of the two mutations and also to investigate whether acquired risk factors other than genetic mutations may play a different role in Chinese VTE patients. Thirty-five patients were diagnosed with DVT concomitant PE, 178 patients with DVT, 54 patients with PE and 102 control subjects were recruited. The mutation was determined by the polymerase chain reaction–restriction fragment length polymorphism method. Of all subjects, none was a carrier of factor V Leiden or prothrombin G20210A mutations. The frequency of surgery was significantly higher in the PE group than that in other groups. There was no significant difference among the three groups in other known risk factors. The data presented here indicate that factor V Leiden and prothrombin G20210A mutations are very rare in the Chinese population, and the genetic risk profile of VTE in the Chinese population is different from that in Caucasians.Keywords
This publication has 32 references indexed in Scilit:
- Genetic Susceptibility to Venous ThrombosisNew England Journal of Medicine, 2001
- Guidelines on diagnosis and management of acute pulmonary embolismEuropean Heart Journal, 2000
- The G20210A Mutation of the Prothrombin Gene in Patients with Previous First Episodes of Deep-Vein ThrombosisThrombosis Research, 1999
- Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy MenNew England Journal of Medicine, 1995
- Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.Journal of Clinical Investigation, 1994
- Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosisThe Lancet, 1994
- Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor VThe Lancet, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderlyArchives of internal medicine (1960), 1994
- Construction of Human Gene Libraries from Small Amounts cf Peripheral Blood: Analysis of β-Like Globin GenesHemoglobin, 1982